BSE filing, BSE: 543595. Summary written from the filing by ALFA Finder's alert engine.
EP Biocomposites Ltd: key numbers
- Share price
- ₹90.00
- Market cap
- ₹15.13 Cr
- Revenue (annual)
- ₹13.64 Cr
- Net profit (annual)
- ₹1.46 Cr
- P/E (TTM)
- 10.4×Sector 21.0×
- Promoter holding
- 70.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EP Biocomposites Ltd
All →EP Biocomposites Other Announcement
This filing submits the quarterly shareholding pattern for EP Biocomposites Ltd as required under Regulation 31(1)(b) of SEBI LODR Regulations.
EP Biocomposites Partnership
EP Biocomposites signed a strategic collaboration and consultancy agreement with Malligavad Foundation and Anand Malligavad for water conservation projects, with no upfront monetary consideration.
EP Biocomposites Bags ₹0.92 Cr Order from Beleza by the Beach
EP Biocomposites Limited secured a ₹0.92 Crore order from Beleza by the Beach to install a 70 KLD Sewage Treatment Plant by April 2027.
- Value
- ₹0.92 Cr
- From
- Beleza by the Beach
- Execution
- 30.04.2027
- Sewage Treatment Plant
- 70.0 KLD
EP Biocomposites Investor Presentation: Key Takeaways
EP Biocomposites Limited reported FY26 revenue of ₹1,363.98 lakhs with a 10.69% PAT margin. The company is pivoting towards sustainable infrastructure solutions including bio-digesters and wastewater treatment.
EP Biocomposites Annual Report
EP Biocomposites Ltd has released its 7th Annual Report for the financial year 2025-26, detailing operational highlights and financial performance snapshots.
EP Biocomposites Annual General Meeting
EP Biocomposites Ltd has issued a notice for its 7th Annual General Meeting, scheduled for September 28, 2026, to discuss financial statements and director appointments.
Other annual general meeting announcements
All →Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Vedanta Iron and Steel Annual General Meeting
Vedanta Iron and Steel seeks shareholder approval via postal ballot for seven material related party transaction resolutions. E-voting runs from 29 October to 27 November 2026.
GTPL Hathway Annual General Meeting
GTPL Hathway seeks shareholder approval by postal ballot to appoint Gurjeev Singh Kapoor as Non-Executive Director. E-voting runs November 1 to 30, 2026.
HEG Advanced Materials Annual General Meeting
HEG Advanced Materials seeks approval via postal ballot to appoint seven directors and fix MD Riju Jhunjhunwala's remuneration. E-voting runs October 29 to November 27, 2026.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.
Sonaselection India Annual General Meeting
Sonaselection India's AGM on 25 Sep 2026 passed all three ordinary resolutions, including adoption of FY2026 audited accounts. Each resolution received 100% of votes polled in favour, with 88.43% of outstanding shares voting.